HF2703

Purpose of the Bill

The bill aims to prevent drug manufacturers from interfering with access to 340B drugs, which are provided to healthcare organizations to offer medications at reduced prices.

Main Provisions

• The bill seeks to extend the prohibition against drug manufacturers interfering with access to 340B drugs. This program is crucial for ensuring that vulnerable populations have access to affordable medication.
• The existing law that would expire in 2027 is repealed, removing the expiration provision. This effectively maintains the prohibition indefinitely, ensuring continuous access to these critical medications.

Significant Changes to Existing Law

• This bill repeals the expiration of Minnesota Statutes 2024 section 62J.96 subdivision 3, which originally set an end date for the prohibition on interference with access to 340B drugs as of July 1, 2027. By removing this expiration, the protection becomes permanent.

Relevant Terms

340B drugs, drug manufacturers, access to medication, repeal, affordable medication, healthcare organizations.